|


About Us
Meet the Partners
Paragon's Mission
Completed Transactions

The Paragon Process
- Step by Step
Strategic Exit Planning

Valuations
- Pre-Market Assessment

Search Current Listings
Healthcare Done Deals
Buyer Qualification Profile

Seller Testimonials
Completed Transactions

Buyer
Resources
Seller
Resources
Seminars & Presentations
Publications
Healthcare Done Deals
M&A Articles
Industry Associations
Helpful Links

If you are considering selling your business within the next year or so, the
time to start is now. Strategic planning far in advance of the actual
event can significantly add to the eventual sales price.
- - -
View Available

Healthcare Business
For Sale
- - -

Click here for
recent healthcare transactions
 |
• New York • Philadelphia
• New England • Los
Angeles • Orlando •
|
|
.
CONCENTRIX
REPORT
We explore the relationship between buyers and sellers to consummate
transactions within specific healthcare sectors. The Paragon
Concentrix Ratings are designed to provide an easy reference of
the supply and demand for each niche business segment. It
monitors and balances current buyer appetite with seller interest
and the strength of market valuation.
Concentrix ratings and market maker categories are based on trends
of actual transactions closed within the past 18 months, public and
private acquisition profiles and interviews conducted by Paragon
Ventures across the spectrum of buyers. Many subjective and
objective factors are used to influence our Concentrix ratings
including revenue size and profitability levels of each enterprise.
Valuation ratings are a blend of strategic and financial sponsor
valuation criteria. A five year rolling average is used to
determine relative strengths and weakness in the current market.
The Current State Of
The Healthcare M&A Market
Q1
2010
Update
·
This market Concentrix report finds many sectors
continuing to be in strong demand despite the global economic
turmoil. Private equity driving interest in privately held,
mid-market businesses with strong earnings and sustainable revenue
streams. Despite the public markets
and general economy there is strong interest and transactions are
closing. It is important to understand the process needed to
consummate a transaction to achieve maximum shareholder value.
·
Strong local and regional players (in most every
niche) continue to position themselves for growth and expansion.
· Product
line expansion, synergistic and opportunistic investors continue to
drive deal flow. Concurrently, the private equity activity
continues to increase investment throughout the healthcare sector.
·
Private equity investors continue to expand their
investments though acquisition of select niche healthcare
providers.
|
|
|
Sector |
Concentrix Rating
Information |
|
Healthcare IT
Services |
-
Healthcare IT Services - Very strong market
with growing buyer pool from both strategic buyers and private
equity investors. Premium valuations being paid for larger
well established, profitable companies that drive efficiencies
with proprietary products and services. Trend continues to
gain momentum based on companies ability to manage enterprise
customers and drive cost out of the healthcare system..
-
Paragon
Buy/Sell Concentrix rating: B9/S8 - Valuations: V9
-
Current Market Makers:
National strategic buyers - Strategic private equity firms for
both platform opportunities and add-on acquisitions - - Buyers
seeking diversification along verticals
|
|
Healthcare
Staffing |
-
Healthcare Staffing - Very strong market with
growing buyer pool. Premium valuations being paid for larger
well established, profitable companies with 15%+ EBITDA and
strong contractual relationships.
-
Paragon
Buy/Sell Concentrix rating: B9/S8 - Valuations: V9
-
Current Market Makers:
National strategic buyers - Strategic private equity firms for
both platform opportunities and add-on acquisitions
|
|
Home Healthcare - Nursing Services
|
-
Home healthcare/nursing - Continued
consolidation upswing with many buyers looking for critical
mass in key markets. A highly fragmented sector with many
consolidation opportunities. Many buyers keying on the strong
growth trends and the ability to realize significant cost
savings with buyer synergies and integration... leading to
improved profitability.
-
Paragon
Buy/Sell Concentrix rating: B8/S7 - Valuations: V7
-
Current Market
Makers: National strategic buyers - Regional strategic buyers
- Critical mass investors
|
|
Infusion Therapy Pharmacy
|
-
Infusion pharmacy - Very strong market with
growing buyer pool and numerous consolidation opportunities.
Premium valuations being paid for larger well established,
profitable companies with 15%+ EBITDA, annual growth and
diversified therapies. Trend continues to gain momentum based
on growth of the infusion market, convergence of infusables
and increased utilization of pharmaceuticals.
-
Paragon
Buy/Sell Concentrix rating: B9/S8 - Valuations: V9
-
Current Market Makers:
National strategic buyers - Strategic private equity firms for
both platform opportunities and add-on acquisitions - - Buyers
seeking diversification
|
|
Institutional
Pharmacy and Support Services |
-
Institutional pharmacy and support services -
Very strong market with growing buyer pool. Continuing
consolidation as buyers looking to expand geographic
coverage. Acquisitions providing strong economies of scale
with consolidated back office and integrated buying power.
-
Paragon
Buy/Sell Concentrix rating: B9/S8 - Valuations: V9
-
Current Market Makers:
National strategic buyers - Strategic private equity firms for
both platform opportunities and add-on acquisitions - - Buyers
seeking diversification into long term care sector from
synergistic vantage points.
|
|
Hospice Services |
-
Hospice - Strong interest from both public and
private equity looking to expand market share.
-
Paragon
Buy/Sell Concentrix rating: B9/S9 - Valuations: V7
-
Current Market
Makers: National strategic buyers - Regional strategic buyers
- Critical mass investors
|
|
Medical Device |
-
Medical Device - Cost efficient, proprietary
devices with strong national and international presence are
driving demand from both vertically integrated strategic
buyers and private equity.
-
Paragon
Buy/Sell Concentrix rating: B8/S7 - Valuations: V7
-
Current Market
Makers: Strategic buyers looking for both diversification and
cost reduction plays across sectors - Strong international
interest for manufacturing efficiencies.
|
|
Medical Asset
Management |
-
Medical Asset Management -
-
Paragon
Buy/Sell Concentrix rating: B8/S7 - Valuations: V7
-
Current Market
Makers: Private Equity Firms - National strategic buyers -
Regional strategic buyers - Individual investors
|
|
Medical Equipment Distribution (HME)
|
-
HME - Larger, multi-location retail operations
in demand. Stronger valuations for those businesses with
strong retail, private pay and non-Medicare payor mixes.
Valuations adjusted for reimbursement changes. This continues
to be a highly fragmented sector with many consolidation
opportunities for business owners with realistic valuation
expectations from the current market.
-
Paragon
Buy/Sell Concentrix rating: B4/S8
- Valuations: V4
-
Current Market Makers: A few
strategic national buyers - Local/Regional strategic buyers -
value investors - - Buyers seeking diversification,
demographic and critical mass investors.
|
|
Medical Supply and Product Distribution
Mail Order |
-
Medical Supplies - Consolidation opportunities
continue as buyers look to increasing critical mass and lower
cost of patient acquisition. Diabetic, Incontinence,
Urologicals, Enteral - Strong market and premium valuations.
Diversified payor mix. Growing buyer universe. Mail order and
alternative distribution models highly desirable.
-
Paragon
Buy/Sell Concentrix rating: B8/S8 -
Valuations: V8
-
Current Market Makers: Multiple
strategic national buyers - local/regional strategic buyers -
national distribution companies - strategic private equity
firms - value investors - - Buyers seeking diversification and
critical mass investors
|
|
Respiratory Care Products and Services |
-
Respiratory - Local and regional buyers (along
with private equity firms for larger opportunities) has filled
the gaps in many markets. Valuations are slightly depressed
based on the impact of reimbursement changes on earnings.
Diversity of payors i.e. specifically non-Medicare payors, has
supported premium valuations, especially in key geographies.
Interest continues to be driven by demographics.
-
Paragon
Buy/Sell Concentrix rating: B4/S7 - Valuations: V5
-
Current Market
Makers: A few strategic national buyers - Local/Regional
strategic buyers - Geographic expansion and competitive
position, demographic and critical mass buyers.
Individuals and family trusts also interested in smaller sub
$10M opportunities for retiring business owners.
|
|
Revenue Cycle Management
|
-
Revenue Cycle Management - Efficient,
profitable and growing businesses are in strong demand. Those
business models that drive cost out of the system and provide
synergies and efficiencies with minimal touch receiving
highest valuations.
-
Paragon
Buy/Sell Concentrix rating: B9/S6 - Valuations: V9
-
Current Market
Makers: Private equity and strategic buyers
|
|
Sleep Diagnostics - Sleep Labs and Sleep Products
|
-
Sleep Diagnostics - Strong market for
established sleep labs with turn-key operations. A highly
fragmented sector with many consolidation opportunities - Many
buyers looking in key markets. Valuations have improved with
the entrance of a number of private equity players who are
using diversified platforms to enter the sleep market.
-
Paragon
Buy/Sell Concentrix rating: B8/S7 - Valuations: V7
-
Current Market
Makers: Private Equity Firms - National strategic buyers -
Regional strategic buyers - Individual investors
|
|
|
The
market for healthcare companies, not unlike the economy of our great
Nation, has always been cyclical. The factors that influence the
flow of investment and divestiture is as broad as the diversity of
companies serving the healthcare needs in America.
Buyers buy and sellers sell - often for different reasons. The key
to success in any business endeavor is a realistic strategic plan
and executing that plan to fulfill specific goals. Every business,
sooner or later, will either be sold, merged, bequeathed or closed.
Therefore, every strategic plan should always include an exit
strategy that takes full advantage of market dynamics and positions
the company for premium valuation. With that said, let's take a
birds-eye view of the current market and examine factors influencing
buyers acquisitions and sellers divestiture or merger of their
enterprises.
The healthcare market is a very broad category and needs to be
viewed in the context of the specific niche sector businesses. To
understand the dynamics of the healthcare market we first need to
understand the players.
Buyers
Buyers generally fall into several specific
categories:
-
National Strategic buyers - These buyers own
similar businesses with numerous locations serving multiple states
(national) and are looking to expand geographically or to add
depth within an existing geography, or to expand into new product
lines.
-
Local/Regional Strategic Buyers - These
buyers own similar businesses with one or more locations/markets
and are looking to expand geographically, or to add depth within
an existing geography, or to expand into new product lines
-
Strategic Private Equity Firms - These
investors (Click here
to read the article, New Titans of Wall Street) invest funds
from various private sources (academic, institutional, high net
worth individuals) coupled with various forms of mezzanine and
other forms of debt. Transactions with strategic private equity
firms provides several unique opportunities/benefits which differ
from standard strategic acquirers.
-
Value Buyers - These investors focus
primarily on the economic dynamics of the acquisition candidate.
The value buyers will focus on using primarily debt financing to
fund the transaction while preserving cash.
Buyers are buying in an effort to:
-
Realize superior returns on investment
-
Gain strategic market position and obtain critical
mass
-
Procure market opportunities
-
Diversify product lines and/or payor mix
Sellers
As a seller, you want to make certain that the marketing of your
company comes on a timeline that you have carefully planned and
prepared for in advance of the actual event.
Sellers are considering selling today because of
various reasons including:
Fear of the future should never be the primary factor
that forces you to sell your business before the company and the
market are ready. Proper pre-planning, skillful exit strategy
execution and consulting with an industry M&A expert are critical to
success in any market.
For more information on our State of the Market report and
Concentrix ratings, please contact Paragon Ventures
800-719-1555.
|


Paragon Ventures is one of the
nation's leading specialists in the merger,
acquisition and divestiture of private mid-market companies. As an intermediary with experience and expertise
we can facilitate the
entire process of buying or selling a business. We specialize in the health care
industries including all aspects of the home healthcare, respiratory care,
infusion therapies, nursing services, medical manufacturing, distribution and
related medical technologies.
Paragon Ventures follows
a proven
process for success where we can consistently and reliably perform. Our mission is to
Unlock the Value,
Create
Opportunity and
Achieve Results. Paragon Ventures
best serves established, profitable, mid-market companies who are looking to
either acquire synergistic organizations or execute an exit strategy.
Whether you are looking at
purchasing a business or trying to sell your own company, we are committed to
facilitating the process from beginning to end.
Paragon Ventures' extensive transactional
experience throughout the healthcare industry including:
We have developed
the effective strategies, proven processes and extensive buyer relationships
which deliver the maximum Real Value® for our clients during the sale or
merger of their company.
Our client
reference list is available upon request, please call 800-719-1555.
|
It's
All About Value

|
Click here to view our
Capabilities Brochure
800-719-1555
If you are interested in
new growth opportunities, consolidation or selling your existing business,
feel free to call one of the Paragon Ventures™ partners directly with
any questions you may have or complete our
on-line
inquiry form.
|

Click
here to
schedule
a private conference
or call
1-800-719-1555.

"We
are what we repeatedly do... Excellence, then, is not an act but a habit."
Aristotle
|